RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in…
$4.54-9.02%
报价 2026-11-06
市值
$188.8M
EV
$254.8M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -65.3%
$4.51$13.09
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RXSTRxSight, Inc. | $188.8M | -9.0% | -1.7% | 76.6% | – | – | – | |
| BFLYButterfly Network, Inc. | $1.7B | +4.9% | +36.1% | 73% | – | – | – | 高增长 |
| KIDSOrthoPediatrics Corp. | $829.3M | -1.4% | +12.9% | 73.8% | – | 364.7x | 253.5x | GARP |
| TCMDTactile Systems Technology, Inc. | $583.1M | -1.3% | +14.1% | 75.2% | 31.1x | 13.8x | 14.4x | GARP |
| DCTHDelcath Systems, Inc. | $518.1M | +3.0% | +22.1% | 87.1% | 1515.5x | 312.9x | 32.9x | GARP |
| DMACDiaMedica Therapeutics Inc. | $504.7M | +3.5% | +10700.0% | 0% | – | – | – | |
| NPCENeuroPace, Inc. | $429.1M | -1.5% | +4.8% | 77.2% | – | – | – | |
| CERSCerus Corporation | $407.9M | -5.2% | +9.4% | 52.1% | – | 226.7x | – | |
| TMCITreace Medical Concepts, Inc. | $262.1M | -3.6% | -2.7% | 79.5% | – | – | – | |
| 同行中位数 | – | – | +13.5% | 74.5% | 773.3x | 269.8x | 32.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。